MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
347.03%
Quick Ratio
347.03%
Cash Ratio
237.95%
Debt to Asset Ratio
46.29%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued liabilities and other li...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
15,260
15,167
25,982
7,324
Marketable securities
4,828
14,576
15,836
21,786
Prepaid expenses and other current assets
2,167
1,998
1,929
3,530
Total current assets
22,255
31,741
43,747
32,640
Property and equipment, net
283
2,990
3,273
3,638
Right of use assets
-
2,399
2,617
2,785
Other assets
82
847
546
550
Total assets
22,620
37,977
50,183
39,613
Accounts payable
2,578
3,070
2,011
2,391
Accrued liabilities and other liabilities
3,835
3,821
8,555
8,604
Total current liabilities
6,413
6,891
10,566
10,995
Lease liabilities, long term
3,603
3,879
4,148
4,411
Other long-term liabilities
455
491
526
561
Total liabilities
10,471
11,261
15,240
15,967
Common stock, par value of 0.001 per share 100,000,000 shares authorized at june 30, 2026 and december 31, 2025 4,068,951 and 3,505,621 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
4
4
4
3
Additional paid-in capital
472,816
472,490
470,898
450,170
Accumulated other comprehensive (loss) income
-3
-2
21
17
Accumulated deficit
-460,668
-445,776
-435,980
-426,544
Total stockholders' equity
12,149
26,716
34,943
23,646
Total liabilities and stockholders' equity
22,620
37,977
50,183
39,613
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$15,260K (211.94%↑ Y/Y)Marketable securities$4,828K (-84.13%↓ Y/Y)Prepaid expenses andother current assets$2,167K (-53.96%↓ Y/Y)Total current assets$22,255K (-44.38%↓ Y/Y)Property and equipment,net$283K (-93.22%↓ Y/Y)Other assets$82K (-85.23%↓ Y/Y)Total assets$22,620K (-52.57%↓ Y/Y)Total liabilities andstockholders' equity$22,620K (-52.57%↓ Y/Y)Total stockholders'equity$12,149K (-59.02%↓ Y/Y)Total liabilities$10,471K (-34.73%↓ Y/Y)Accumulated deficit-$460,668K (-10.23%↓ Y/Y)Accumulated othercomprehensive (loss) income-$3K (57.14%↑ Y/Y)Additional paid-in capital$472,816K (5.64%↑ Y/Y)Total currentliabilities$6,413K (-40.52%↓ Y/Y)Lease liabilities,long term$3,603K (-22.78%↓ Y/Y)Other long-termliabilities$455K (-23.66%↓ Y/Y)Common stock, par valueof 0.001 per share...$4K (100.00%↑ Y/Y)Accrued liabilities andother liabilities$3,835K (-53.44%↓ Y/Y)Accounts payable$2,578K (1.34%↑ Y/Y)

NextCure, Inc. (NXTC)

NextCure, Inc. (NXTC)